Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2026-02-11 @ 9:21 AM
Study NCT ID:
NCT01681433
Status:
TERMINATED
Last Update Posted:
2022-07-11
First Post:
2012-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
Sponsor:
Costantine Albany
Organization: